1. Introduction: An Overview of the non-parenteral delivery of nanomedicine2. Challenges in non-parenteral nanomedicine therapy3. Regulatory implication of non-parenteral nanomedicine4. Physiology of the biological barriers5. Mucoadhesive polymers in the design of nanocarrier6. Mucoadhesive polymers, lipids used in solid lipid nanoparticles7. Mucus penetrating nanocarrier8. Nanomedicines developed for ocular drug delivery9. From the nose to the brain, nanomedicine drug delivery10. Oral drug delivery of nanomedicines11. Nanomedicine for inflammatory bowel disease12. Nanomedicine for vaginal drug delivery13. Nanomedicine in reproductive biology14. Regenerative nanomedicine, emerging non-parenteral applications15. Electrospun nanofibers for wound healing16. Nanomedicine in pulmonary delivery17. Nanomedicine and pain management18. Transdermal delivery of nanomedicine19. Nanomedicine and insulin delivery20. Non-parenteral nanoparticles in consumer products21. Post-operative local administration of nanomedicine22. Hydrogel for therapeutic delivery of nanomedicine23. Regulatory pathway to introduce a nanomedicine product on the market at international level24. Non-parenteral nanoparticles in consumer products